Regulatory status by jurisdiction: difference between revisions
Diff·revision 12 → 13·04:27, 1 May 2025
Difference between revision 12 and revision 13 of Regulatory status by jurisdiction. 3 lines changed; the page grew by 271 bytes.
| Revision 12 — 22:08, 11 Apr 2025 FiveOhThreeB (talk) state that the position differs between jurisdictions and give two examples 3,391 bytes ±0 | Revision 13 — 04:27, 1 May 2025 Compounding_Cate (talk) attribute the compounding statement to the pharmacy board that issued it 3,662 bytes +271 | ||
|---|---|---|---|
| 6 | | Consequence = The same molecule differs in status between countries | 6 | | Consequence = The same molecule differs in status between countries |
| 7 | }} | 7 | }} |
| + | 8 | {{cleanup|talk=Structure of the jurisdiction material}} | |
| 8 | 9 | ||
| 9 | '''Regulatory status by jurisdiction''' describes how the legal treatment of a substance differs between countries. Status follows from the regulatory category a substance occupies in a given jurisdiction, and the same molecule may be a licensed medicine in one, an unapproved investigational compound in another, and a research reagent in a third.{{r|wco}} | 10 | '''Regulatory status by jurisdiction''' describes how the legal treatment of a substance differs between countries. Status follows from the regulatory category a substance occupies in a given jurisdiction, and the same molecule may be a licensed medicine in one, an unapproved investigational compound in another, and a research reagent in a third.{{r|wco}} |
| ⋮ | ⋮ | ||
| 30 | 31 | ||
| 31 | Scheduling decisions are made nationally and reflect local policy. Substances prohibited in sport under anti-doping rules are subject to a separate regime again, which is contractual rather than legal in most cases.{{r|wco}} | 32 | Scheduling decisions are made nationally and reflect local policy. Substances prohibited in sport under anti-doping rules are subject to a separate regime again, which is contractual rather than legal in most cases.{{r|wco}} |
| + | 33 | ||
| + | 34 | Sub-national variation exists in federal systems, particularly for compounding and dispensing, which is why [[503A compounding pharmacy|compounding]] rules cannot be summarised at national level alone.{{r|ich_q7}} | |
| 32 | 35 | ||
| 33 | == References == | 36 | == References == |